Image courtesy of 123rf.com

UnitedHealth Group (UNH) shares experienced a dramatic surge of over 12% in premarket trading on Friday, August 15, 2025, following the revelation that Berkshire Hathaway had taken a new stake in the beleaguered healthcare giant. The investment comes at a critical time for UnitedHealth, which has been the worst performer on the Dow Jones Industrial Average this year, falling nearly 46% amid a series of operational challenges including rising healthcare costs, regulatory scrutiny, and cybersecurity incidents. Berkshire’s vote of confidence in the company appears to have provided much-needed momentum for the stock, which had been trading at $271.49 at the previous close before jumping to $305.80 in premarket trading.

Berkshire Hathaway’s Strategic Investment in UnitedHealth Creates Stock Price Surge

Berkshire Hathaway disclosed ownership of 5.04 million UnitedHealth shares worth approximately $1.57 billion as of June 30, according to a Securities and Exchange Commission filing. This investment represents a significant vote of confidence from one of the world’s most respected investment firms in a company that has faced substantial headwinds throughout 2025. The timing of Berkshire’s investment is particularly noteworthy, as it comes during a period when UnitedHealth has been grappling with elevated operational challenges and market skepticism.

The investment also had a positive spillover effect on other healthcare insurers, with rivals Centene and Molina Healthcare climbing more than 4% each in premarket trading. Berkshire simultaneously disclosed new stakes in other companies including steel maker Nucor, security products provider Allegion, and outdoor advertiser Lamar Advertising, indicating a broader diversification strategy.

UnitedHealth: Did Berkshire Hathaway Buy the Dip?

UnitedHealth’s stock performance has been severely impacted by a confluence of challenges that have made it the worst performer on the blue-chip Dow Jones Industrial Average in 2025, with shares declining nearly 46% year-to-date compared to the S&P 500’s 9.98% gain.

The company has been dealing with rising healthcare costs, a Department of Justice probe into its billing practices, a significant cyberattack that impacted 192.7 million people, and the high-profile murder of former executive Brian Thompson in December 2024. These issues culminated in CEO Andrew Witt’s abrupt resignation in May, with former CEO Stephen Hemsley returning to lead the company.

Despite these challenges, UnitedHealth maintains strong underlying fundamentals with a market capitalization of $245.88 billion, trailing P/E ratio of 11.75, and profit margin of 5.04%.

The company’s shares are currently trading at about 15.8 times forward earnings estimates, below their five-year average of 19, suggesting potential undervaluation. However, the company recently projected full-year adjusted earnings per share of at least $16, falling short of analysts’ already lowered expectations, while second-quarter profit also missed Wall Street estimates, indicating ongoing operational pressures in the near term.

More By This Author:

Intel Continues Gains In Premarket Amid Reports Of U.S. Gov Seeking INTC Stake
Ethereum’s Moment? Why $10K ETH Is Back On The Table
Amazon’s Shares Gain As Firm Expands Its Same-Day Grocery Delivery Service